
    
      A single arm,open,phase II study of Nab-Paclitaxel plus Capecitabine as the first-line
      treatment in advanced gastric cancer.

      Nab-Paclitaxel should be given intravenously on days 1 and 8 at a dose as follows. Treatment
      should be repeated every 3 weeks:Nab-Paclitaxel:125 mg/m2; Capecitabine should be given
      orally twice a day as follows for 14 consecutive days, followed by a 1-week rest. Treatment
      should be repeated every 3 weeks. Capecitabine:1000mg/m2,twice daily (bid).

      If applicable,the value of response and prognosis predictive factors are expected to be
      identified.
    
  